相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Fernando Gordillo Altamirano et al.
NATURE MICROBIOLOGY (2021)
Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment
Emily Engeman et al.
PHARMACEUTICALS (2021)
Preclinical data and safety assessment of phage therapy in humans
Janet Y. Nale et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance
Pengxiao Zuo et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2021)
Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections
Joshua J. Iszatt et al.
VIRUSES-BASEL (2021)
Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture
Xiaoqing Wang et al.
EMERGING MICROBES & INFECTIONS (2021)
Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis
Holger Mueller-Redetzky et al.
ANESTHESIOLOGY (2020)
Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies
Mihnea R. Mangalea et al.
INFECTION AND IMMUNITY (2020)
Standardized bacteriophage purification for personalized phage therapy
Tiffany Luong et al.
NATURE PROTOCOLS (2020)
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States
Saima Aslam et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages
Katarzyna Hodyra-Stefaniak et al.
PHAGE-THERAPY APPLICATIONS AND RESEARCH (2020)
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kaitlyn E. Kortright et al.
CELL HOST & MICROBE (2019)
Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
Helio S. Sader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
Nancy Law et al.
INFECTION (2019)
Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia
Josef Prazak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice
Nicolas Dufour et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Patrick Jault et al.
LANCET INFECTIOUS DISEASES (2019)
Digital Image Analyses on Whole-Lung Slides in Mouse Models of Acute Pneumonia
Kristina Dietert et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo
Kyoungeun Cha et al.
FRONTIERS IN MICROBIOLOGY (2018)
Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
Yunfen Hua et al.
FRONTIERS IN MICROBIOLOGY (2018)
Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections
Rachit Agarwal et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Phage therapy for respiratory infections
Rachel Yoon Kyung Chang et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital
Eli Ben-Chetrit et al.
CRITICAL CARE (2018)
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Sarah Berger et al.
CRITICAL CARE (2018)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections
Elsa Bodier-Montagutelli et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Tyk2 as a target for immune regulation in human viral/bacterial pneumonia
Johanna Berg et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia
Kristina Dietert et al.
PLOS ONE (2017)
A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models
Minmin Yen et al.
Nature Communications (2017)
Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages
Jonas D. Van Belleghem et al.
SCIENTIFIC REPORTS (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen
Dwayne R. Roach et al.
CELL HOST & MICROBE (2017)
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams
Nicolas Dufour et al.
CLINICAL INFECTIOUS DISEASES (2017)
Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung
Rishi Pabary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357
Jongsoo Jeon et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia
M. P. Freire et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro
Maria Lazaro-Diez et al.
MICROBES AND INFECTION (2016)
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
Shafiqul Alam Sarker et al.
EBIOMEDICINE (2016)
On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy
Sari Mattila et al.
FRONTIERS IN MICROBIOLOGY (2015)
Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity
Fatima Kamal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections
Diana D. Semler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens
Tania Mareike Viertel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii
Maia Merabishvili et al.
PLOS ONE (2014)
Amplification of Aminoglycoside Resistance Gene aphA1 in Acinetobacter baumannii Results in Tobramycin Therapy Failure
Patrick McGann et al.
MBIO (2014)
Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia
Jan M. Doehn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges
Christian A. Ruge et al.
LANCET RESPIRATORY MEDICINE (2013)
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Kolja V. Szymanski et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
Elizabeth M. Ryan et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo
Andre Broermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways
Frederic Perros et al.
RESPIRATORY RESEARCH (2011)
Efficacy of Bacteriophage Therapy in a Model of Burkholderia cenocepacia Pulmonary Infection
Lisa A. Carmody et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
A. Wright et al.
CLINICAL OTOLARYNGOLOGY (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Toward Modern Inhalational Bacteriophage Therapy: Nebulization of Bacteriophages of Burkholderia cepacia Complex
Laleh Golshahi et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice
Sanjay Chhibber et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Andre M. Comeau et al.
PLOS ONE (2007)
Experimental phage therapy against Staphylococcus aureus in mice
Rosanna Capparelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia
S Knapp et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium
B Biswas et al.
INFECTION AND IMMUNITY (2002)